glp 1 agonist pcos Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy Frontiers | Balancing metabolic optimization
Description
[DOI] [PubMed] [Google Scholar] 9.Yen F.S., Yang Y.C., Hwu C.M., Wei J.C., Huang Y.H., Hou M.C., Hsu C.C
138 To date, there are limited data on clinically significant metabolic enzyme- or transporter-mediated DDIs involving GLP-1 RAs and a dual GLP-1/GIP RA
J Am Coll Cardiol (2020) 75(16):195674
Additionally, a nationwide study conducted in Israel found improved IBD outcomes, with a significant reduction of hospitalization rates
